Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
Abbott LaboratoriesABT |
-$4.8B |
 |
Tempus AITEM |
-$7.45B |
 |
TeleflexTFX |
-$40M |
 |
Universal Health ServicesUHS |
-$43M |
 |
HCA HealthcareHCA |
-$256M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| EISENBERG GLENN A | Dec 2, 2024 | Sell | 11,711 | $240.4279 | $2.8M |
| Gilliland Dwight Gary | Dec 2, 2024 | Sell | 1,000 | $241 | $240,000 |
| Summy Amy B. | Nov 22, 2024 | Sell | 3,672 | $238.9055 | $880,000 |
| van der Vaart Sandra D | Nov 21, 2024 | Sell | 1,000 | $239.4187 | $240,000 |
| Schechter Adam H | Nov 11, 2024 | Sell | 6,189 | $243.47 | $1.5M |
| ANDERSON KERRII B | Oct 24, 2024 | Sell | 1,000 | $230 | $230,000 |
| EISENBERG GLENN A | Aug 15, 2024 | Sell | 9,071 | $224.5488 | $2M |
| EISENBERG GLENN A | Aug 15, 2024 | Sell | 2,979 | $222.6494 | $660,000 |
| EISENBERG GLENN A | Aug 15, 2024 | Sell | 2,950 | $223.6169 | $660,000 |
| ANDERSON KERRII B | Aug 8, 2024 | Sell | 586 | $225 | $130,000 |
| ANDERSON KERRII B | Aug 7, 2024 | Sell | 414 | $225 | $93,000 |
| BERBERIAN LANCE | Aug 5, 2024 | Sell | 9,848 | $228.9485 | $2.3M |
| BERBERIAN LANCE | Aug 5, 2024 | Sell | 2,245 | $229.785 | $520,000 |
| van der Vaart Sandra D | May 14, 2024 | Sell | 1,800 | $210.8268 | $380,000 |
| van der Vaart Sandra D | May 14, 2024 | Sell | 200 | $210.835 | $42,000 |
| ANDERSON KERRII B | May 2, 2024 | Sell | 250 | $200.0981 | $50,000 |
| Wilkinson Peter J | Apr 29, 2024 | Sell | 2,439 | $204.329 | $500,000 |
| Schroeder Mark S | Apr 1, 2024 | Sell | 6,477 | $217.29 | $1.4M |
| Summy Amy B. | Apr 1, 2024 | Sell | 3,500 | $217.29 | $760,000 |
| van der Vaart Sandra D | Mar 28, 2024 | Sell | 3,553 | $216.74 | $770,000 |
| Schroeder Mark S | Mar 7, 2024 | Sell | 5,048 | $218.45 | $1.1M |
| Summy Amy B. | Mar 7, 2024 | Sell | 227 | $218.45 | $50,000 |
| EISENBERG GLENN A | Feb 21, 2024 | Sell | 18,379 | $215.3661 | $4M |
| EISENBERG GLENN A | Feb 21, 2024 | Sell | 7,907 | $215.6759 | $1.7M |
| EISENBERG GLENN A | Feb 21, 2024 | Sell | 6,665 | $217.5205 | $1.4M |
| EISENBERG GLENN A | Feb 21, 2024 | Sell | 1,553 | $217.9842 | $340,000 |
| DiVincenzo Jonathan P. | Feb 21, 2024 | Sell | 500 | $215.4901 | $110,000 |
| van der Vaart Sandra D | Feb 13, 2024 | Sell | 237 | $226.45 | $54,000 |
| van der Vaart Sandra D | Feb 8, 2024 | Sell | 259 | $222.06 | $58,000 |
| van der Vaart Sandra D | Feb 5, 2024 | Sell | 193 | $220.57 | $43,000 |
| Wilkinson Peter J | Nov 16, 2023 | Sell | 1,384 | $210.713 | $290,000 |
| ANDERSON KERRII B | Aug 8, 2023 | Sell | 5,000 | $211.5665 | $1.1M |
| van der Vaart Sandra D | Jun 29, 2023 | Sell | 212 | $240 | $51,000 |
| Kirchgraber Paul R | May 19, 2023 | Sell | 4,300 | $216.9086 | $930,000 |
| Schroeder Mark S | May 18, 2023 | Sell | 1,500 | $216.77 | $330,000 |
| Schroeder Mark S | Mar 31, 2023 | Sell | 3,897 | $225.81 | $880,000 |
| Kirchgraber Paul R | Feb 21, 2023 | Sell | 8,000 | $250.5844 | $2M |
| Schroeder Mark S | Feb 14, 2023 | Sell | 309 | $247.63 | $77,000 |
| van der Vaart Sandra D | Feb 7, 2023 | Sell | 219 | $243.01 | $53,000 |
| Schroeder Mark S | Feb 7, 2023 | Sell | 409 | $243.01 | $99,000 |
| van der Vaart Sandra D | Feb 3, 2023 | Sell | 173 | $253.9 | $44,000 |
| Schroeder Mark S | Feb 3, 2023 | Sell | 324 | $253.9 | $82,000 |
What's the latest insider transaction for LabCorp?
The most recent insider transaction for LabCorp was conducted by EISENBERG GLENN A, who sold 11,711 shares on December 2, 2024 at a price of $240.43 per share.
Which insider has sold the most LH stock over the last two years?
EISENBERG GLENN A has sold the most LH stock in the last 2 years, with a total value of $14M.
What is the total value of insider transactions for LabCorp (LH) in the last 2 years?
The total value of insider transactions for LabCorp in the last 2 years is negative, amounting to -$31M. This suggests that insiders have predominantly sold shares, which could reflect various personal or financial considerations rather than a straightforward outlook on the company's future performance.
How do insider transactions over the last 2 years reflect on LabCorp's market confidence?
Over the last 2 years, insider transactions for LabCorp have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Why is monitoring insider trading activity important for investors?
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
